Alzheimer's Research and Therapy

Alzheimer's Research and Therapy

ISSNs: 1758-9193

BioMed Central Ltd.

Scopus rating (2023): CiteScore 13.1 SJR 2.608 SNIP 1.687

Indexed in DOAJ

Journal

Journal Metrics
1 - 2 out of 2Page size: 20

Research Output

  1. 2024
  2. Published

    Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice

    Zhang, N., Sui, Y., Jendrichovsky, P., Feng, H., Shi, H., Zhang, X. & Xu, S. & 5 others, Sun, W., Zhang, H., Chen, X., Tortorella, M. D. & He, J., 2024, In: Alzheimer's Research & Therapy. 16, 109.

    Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

    Scopus citations: 2
    Check@CityULib
  3. Published

    N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk

    Cheng, D., Lei, Z.-G., Chu, K., Lam, O. J. H., Chiang, C. Y. & Zhang, Z.-J., 2024, In: Alzheimer's Research and Therapy. 16, 95.

    Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

    Scopus citations: 10
    Check@CityULib